Triple Helix Discovery Engine
"Triple Helix" Innovation Model
4. Triple Helix _ Capture Strategies
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Research Triangle, North Carolina

Biolex Therapeutics

Parents

*Architects: Biotechnology _Monoclonal, Polyclonal, Bispecific Antibodies & Antibody-Drug Conjugates (ADC)s
*Architects: Biotechnology_Drug & Vaccine Discovery and Development
*Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
*Industry: North Carolina
*Industry: Research Triangle, North Carolina
*Portfolio Companies: Intersouth
*Portfolio Companies: Polaris Venture
*Portfolio Companies: Quaker BioVentures
*Portfolio Companies: Village Ventures
Mitsui & Co, Venture Partners, Ltd
Watch List: Bankruptcy Filing, Financial Collapse

An expression system that enables the production of hard-to-make proteins and the optimization of monoclonal antibodies
Biolex Therapeutics files for $38M bankruptcy (2012)
Biolex's lead candidate, Locteron™, is being developed as a best-in-class controlled-release interferon alfa for the treatment o
BLX-155, is a direct-acting thrombolytic, designed to break up clots in certain diseases such as acute peripheral arterial disea
Research Triangle, North Carolina
Therapeutic proteins based on its proprietary LEX SystemSM